These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 24677741)
1. Simplified silvestrol analogues with potent cytotoxic activity. Hawkins BC; Lindqvist LM; Nhu D; Sharp PP; Segal D; Powell AK; Campbell M; Ryan E; Chambers JM; White JM; Rizzacasa MA; Lessene G; Huang DC; Burns CJ ChemMedChem; 2014 Jul; 9(7):1556-66. PubMed ID: 24677741 [TBL] [Abstract][Full Text] [Related]
2. Synthetic silvestrol analogues as potent and selective protein synthesis inhibitors. Liu T; Nair SJ; Lescarbeau A; Belani J; Peluso S; Conley J; Tillotson B; O'Hearn P; Smith S; Slocum K; West K; Helble J; Douglas M; Bahadoor A; Ali J; McGovern K; Fritz C; Palombella VJ; Wylie A; Castro AC; Tremblay MR J Med Chem; 2012 Oct; 55(20):8859-78. PubMed ID: 23025805 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of biotinylated episilvestrol: highly selective targeting of the translation factors eIF4AI/II. Chambers JM; Lindqvist LM; Webb A; Huang DC; Savage GP; Rizzacasa MA Org Lett; 2013 Mar; 15(6):1406-9. PubMed ID: 23461621 [TBL] [Abstract][Full Text] [Related]
4. 1-Aminomethyl SAR in a novel series of flavagline-inspired eIF4A inhibitors: Effects of amine substitution on cell potency and in vitro PK properties. Nilewski C; Michels TD; Packard GK; Xiang AX; Sprengeler PA; Eam B; Fish S; Thompson PA; Wegerski CJ; Nevarez A; Clarine J; Sperry S; Ernst JT; Reich SH Bioorg Med Chem Lett; 2021 Sep; 47():128111. PubMed ID: 34353608 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of rocaglamide hydroxamates and related compounds as eukaryotic translation inhibitors: synthetic and biological studies. Rodrigo CM; Cencic R; Roche SP; Pelletier J; Porco JA J Med Chem; 2012 Jan; 55(1):558-62. PubMed ID: 22128783 [TBL] [Abstract][Full Text] [Related]
6. Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol. Cencic R; Carrier M; Galicia-Vázquez G; Bordeleau ME; Sukarieh R; Bourdeau A; Brem B; Teodoro JG; Greger H; Tremblay ML; Porco JA; Pelletier J PLoS One; 2009; 4(4):e5223. PubMed ID: 19401772 [TBL] [Abstract][Full Text] [Related]
7. Stress Granule-Inducing Eukaryotic Translation Initiation Factor 4A Inhibitors Block Influenza A Virus Replication. Slaine PD; Kleer M; Smith NK; Khaperskyy DA; McCormick C Viruses; 2017 Dec; 9(12):. PubMed ID: 29258238 [TBL] [Abstract][Full Text] [Related]
8. ATP-competitive, marine derived natural products that target the DEAD box helicase, eIF4A. Tillotson J; Kedzior M; Guimarães L; Ross AB; Peters TL; Ambrose AJ; Schmidlin CJ; Zhang DD; Costa-Lotufo LV; Rodríguez AD; Schatz JH; Chapman E Bioorg Med Chem Lett; 2017 Sep; 27(17):4082-4085. PubMed ID: 28757063 [TBL] [Abstract][Full Text] [Related]
9. Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris. Hwang BY; Su BN; Chai H; Mi Q; Kardono LB; Afriastini JJ; Riswan S; Santarsiero BD; Mesecar AD; Wild R; Fairchild CR; Vite GD; Rose WC; Farnsworth NR; Cordell GA; Pezzuto JM; Swanson SM; Kinghorn AD J Org Chem; 2004 May; 69(10):3350-8. PubMed ID: 15132542 [TBL] [Abstract][Full Text] [Related]
10. Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (-) and the eIF4A-inhibitor Silvestrol. Müller C; Obermann W; Schulte FW; Lange-Grünweller K; Oestereich L; Elgner F; Glitscher M; Hildt E; Singh K; Wendel HG; Hartmann RK; Ziebuhr J; Grünweller A Antiviral Res; 2020 Mar; 175():104706. PubMed ID: 31931103 [TBL] [Abstract][Full Text] [Related]
11. New lupane derived compounds with pro-apoptotic activity in cancer cells: synthesis and structure-activity relationships. Sarek J; Klinot J; Dzubák P; Klinotová E; Nosková V; Krecek V; Korínková G; Thomson JO; Janost'áková A; Wang S; Parsons S; Fischer PM; Zhelev NZ; Hajdúch M J Med Chem; 2003 Dec; 46(25):5402-15. PubMed ID: 14640549 [TBL] [Abstract][Full Text] [Related]
12. Inhibitors of translation initiation as cancer therapeutics. Lindqvist L; Pelletier J Future Med Chem; 2009 Dec; 1(9):1709-22. PubMed ID: 21425987 [TBL] [Abstract][Full Text] [Related]
13. The natural compound silvestrol is a potent inhibitor of Ebola virus replication. Biedenkopf N; Lange-Grünweller K; Schulte FW; Weißer A; Müller C; Becker D; Becker S; Hartmann RK; Grünweller A Antiviral Res; 2017 Jan; 137():76-81. PubMed ID: 27864075 [TBL] [Abstract][Full Text] [Related]
14. Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses. Müller C; Schulte FW; Lange-Grünweller K; Obermann W; Madhugiri R; Pleschka S; Ziebuhr J; Hartmann RK; Grünweller A Antiviral Res; 2018 Feb; 150():123-129. PubMed ID: 29258862 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives. Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972 [TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI. Zakowicz H; Yang HS; Stark C; Wlodawer A; Laronde-Leblanc N; Colburn NH RNA; 2005 Mar; 11(3):261-74. PubMed ID: 15661843 [TBL] [Abstract][Full Text] [Related]
19. Total synthesis of a biotinylated rocaglate: Selective targeting of the translation factors eIF4AI/II. Chambers JM; Lindqvist LM; Savage GP; Rizzacasa MA Bioorg Med Chem Lett; 2016 Jan; 26(2):262-264. PubMed ID: 26718843 [TBL] [Abstract][Full Text] [Related]
20. Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A. Bordeleau ME; Mori A; Oberer M; Lindqvist L; Chard LS; Higa T; Belsham GJ; Wagner G; Tanaka J; Pelletier J Nat Chem Biol; 2006 Apr; 2(4):213-20. PubMed ID: 16532013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]